Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial.

Khai P NgPoorva JainParamjit S GillGurdip HeerJonathan N TownendNick FreemantleSheila GreenfieldRichard J McManusCharles J Ferro

Published in: BMJ open (2016)

ISRCTN80658312.